Categories AlphaGraphs, Earnings, Health Care

AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues

Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm’s earnings declined.

Amgen Q4 2022 earnings infographic

Unadjusted earnings decreased to $4.09 per share in the December quarter from $4.40 per share in the year-ago period. The reported net income was $1.62 billion or $3.0 per share in the latest quarter, compared to $1.90 billion or $3.36 per share in the year-ago quarter.

Meanwhile, total revenues remained unchanged at $6.84 billion during the three-month period. A 4% increase in product sales was offset by weakness in the other business segments.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top